ncRNA possesses little known specificity albeit with much potential to change cellular outcomes. We're building signatures that identify desirable cell states to educate Natural Killer cells.
We presently focus on intron1. We compute all potential subsequence’s (k-mers) of seven or more nucleotides and count k-mer repeats. At each computational step, which starts at the first nucleotide each k-mer is paired to its transcript mRNA signature (m-sig) and ranked into a vector that represents multiple transcripts. For each transcript, k-mers are ordered by repeats and selected for the most significant change in the vector at the next row. Selected k-mers are grouped, deduplicated, identified to their intron1 positions, compared to miRNA or other databases and transfected to test biological results.
We are building a signature database for laboratories to identify cells for use in autologous treatment.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 15260 Ventura Blvd,
- su****@****dex.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- codondex.com
- Keywords
- Bioinformatics, Computational Biology, Genomics, ncDNA, computational genetics, statistical genetics, autologous treatment, Immunotherapy, intron, Precision Medicine.
- HQ
- Sherman Oaks, CA
Codondex Questions
Codondex's website is codondex.com
Codondex's LinkedIn profile is https://www.linkedin.com/company/codondex-llc
Codondex has
2 employees.
View email and phone details for 2
employees at Codondex.
Codondex's industry is
Biotechnology Research
Codondex's top competitors are
Adfreeway - Pretargeted Open Web Advertising,
Ardea Investment Management.
Codondex's support email address is support@codondex.com
Codondex's categories are Biotechnology Research
Codondex's founding year is 2014
